Laura Dunn
Concepts (371)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 47 | 2024 | 1314 | 5.260 |
Why?
| | Informed Consent | 34 | 2017 | 92 | 5.120 |
Why?
| | Decision Making | 30 | 2017 | 273 | 3.730 |
Why?
| | Depression | 26 | 2024 | 603 | 2.480 |
Why?
| | Mental Competency | 23 | 2017 | 32 | 2.470 |
Why?
| | Breast Neoplasms | 31 | 2022 | 1203 | 2.450 |
Why?
| | Patient Participation | 7 | 2019 | 65 | 2.090 |
Why?
| | Anxiety | 15 | 2024 | 305 | 2.040 |
Why?
| | Biomedical Research | 12 | 2019 | 260 | 1.950 |
Why?
| | Fatigue | 22 | 2022 | 126 | 1.920 |
Why?
| | Schizophrenia | 15 | 2008 | 257 | 1.830 |
Why?
| | Quality of Life | 26 | 2023 | 893 | 1.790 |
Why?
| | Adaptation, Psychological | 9 | 2024 | 227 | 1.790 |
Why?
| | Research Subjects | 11 | 2019 | 53 | 1.770 |
Why?
| | Patients | 5 | 2022 | 50 | 1.730 |
Why?
| | Third-Party Consent | 7 | 2013 | 16 | 1.680 |
Why?
| | Clinical Trials as Topic | 15 | 2023 | 461 | 1.590 |
Why?
| | Middle Aged | 100 | 2024 | 13133 | 1.550 |
Why?
| | Clergy | 4 | 2017 | 24 | 1.530 |
Why?
| | Schizophrenic Psychology | 12 | 2011 | 68 | 1.410 |
Why?
| | Alzheimer Disease | 8 | 2021 | 356 | 1.380 |
Why?
| | Female | 122 | 2024 | 28277 | 1.360 |
Why?
| | Caregivers | 12 | 2021 | 239 | 1.340 |
Why?
| | Humans | 159 | 2024 | 52441 | 1.320 |
Why?
| | Antineoplastic Agents | 14 | 2020 | 1216 | 1.310 |
Why?
| | Stress, Psychological | 10 | 2024 | 275 | 1.230 |
Why?
| | Proxy | 4 | 2013 | 8 | 1.210 |
Why?
| | Ethics, Research | 6 | 2016 | 39 | 1.160 |
Why?
| | Aged | 76 | 2024 | 10242 | 1.140 |
Why?
| | Depressive Disorder | 9 | 2023 | 335 | 1.120 |
Why?
| | Psychiatry | 6 | 2018 | 99 | 1.120 |
Why?
| | Cognition Disorders | 11 | 2021 | 213 | 1.090 |
Why?
| | Male | 94 | 2024 | 26874 | 1.090 |
Why?
| | Mental Disorders | 6 | 2019 | 427 | 1.080 |
Why?
| | Psychotic Disorders | 10 | 2018 | 139 | 1.080 |
Why?
| | Adult | 62 | 2024 | 14205 | 1.050 |
Why?
| | Comprehension | 7 | 2016 | 114 | 1.020 |
Why?
| | Psychotherapy | 6 | 2021 | 112 | 0.990 |
Why?
| | Spiritual Therapies | 2 | 2017 | 5 | 0.970 |
Why?
| | Patient Preference | 2 | 2016 | 43 | 0.970 |
Why?
| | Cytokines | 10 | 2017 | 622 | 0.950 |
Why?
| | Palliative Care | 4 | 2017 | 194 | 0.950 |
Why?
| | Needs Assessment | 3 | 2018 | 141 | 0.940 |
Why?
| | Longitudinal Studies | 32 | 2024 | 756 | 0.910 |
Why?
| | Dementia | 3 | 2017 | 168 | 0.880 |
Why?
| | Personality | 2 | 2022 | 29 | 0.830 |
Why?
| | Therapeutic Misconception | 4 | 2017 | 4 | 0.790 |
Why?
| | Ambulatory Care | 8 | 2017 | 238 | 0.780 |
Why?
| | Internship and Residency | 5 | 2011 | 438 | 0.780 |
Why?
| | Genetic Research | 2 | 2019 | 4 | 0.780 |
Why?
| | Mastectomy | 8 | 2021 | 145 | 0.760 |
Why?
| | Aged, 80 and over | 23 | 2020 | 3449 | 0.700 |
Why?
| | Psychiatric Status Rating Scales | 8 | 2017 | 324 | 0.700 |
Why?
| | Polymorphism, Single Nucleotide | 14 | 2017 | 506 | 0.690 |
Why?
| | Severity of Illness Index | 23 | 2019 | 1045 | 0.680 |
Why?
| | Health Services Research | 4 | 2016 | 153 | 0.670 |
Why?
| | Radiotherapy | 3 | 2018 | 128 | 0.650 |
Why?
| | Geriatric Psychiatry | 3 | 2017 | 9 | 0.640 |
Why?
| | Self Concept | 1 | 2020 | 63 | 0.630 |
Why?
| | Patient Rights | 1 | 2019 | 2 | 0.620 |
Why?
| | Deep Brain Stimulation | 3 | 2020 | 42 | 0.600 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 177 | 0.590 |
Why?
| | Chaplaincy Service, Hospital | 2 | 2015 | 2 | 0.580 |
Why?
| | Choroid Neoplasms | 1 | 2018 | 6 | 0.570 |
Why?
| | Pastoral Care | 1 | 2018 | 5 | 0.560 |
Why?
| | Cyclonic Storms | 1 | 2018 | 8 | 0.560 |
Why?
| | Eye Enucleation | 1 | 2018 | 11 | 0.560 |
Why?
| | Anxiety Disorders | 5 | 2022 | 128 | 0.560 |
Why?
| | Disasters | 1 | 2018 | 19 | 0.560 |
Why?
| | Resilience, Psychological | 4 | 2024 | 32 | 0.520 |
Why?
| | Education | 2 | 2010 | 39 | 0.510 |
Why?
| | Self Report | 13 | 2021 | 221 | 0.510 |
Why?
| | Circadian Rhythm | 5 | 2016 | 92 | 0.500 |
Why?
| | Outpatients | 9 | 2022 | 128 | 0.500 |
Why?
| | Genetic Variation | 4 | 2014 | 226 | 0.490 |
Why?
| | Comorbidity | 11 | 2021 | 637 | 0.490 |
Why?
| | Research Personnel | 5 | 2019 | 71 | 0.480 |
Why?
| | Attitude of Health Personnel | 2 | 2011 | 358 | 0.470 |
Why?
| | Interdisciplinary Studies | 1 | 2015 | 4 | 0.470 |
Why?
| | Pain | 8 | 2022 | 373 | 0.460 |
Why?
| | Research | 3 | 2006 | 109 | 0.460 |
Why?
| | Multimedia | 4 | 2021 | 7 | 0.450 |
Why?
| | Melanoma | 1 | 2018 | 272 | 0.450 |
Why?
| | Mastodynia | 5 | 2016 | 6 | 0.440 |
Why?
| | Aging | 5 | 2015 | 722 | 0.440 |
Why?
| | Syndrome | 5 | 2023 | 247 | 0.430 |
Why?
| | Internet | 3 | 2016 | 262 | 0.430 |
Why?
| | Cross-Sectional Studies | 11 | 2022 | 1677 | 0.430 |
Why?
| | Fear | 1 | 2014 | 84 | 0.420 |
Why?
| | Survivors | 1 | 2014 | 121 | 0.420 |
Why?
| | Patient Education as Topic | 4 | 2011 | 317 | 0.410 |
Why?
| | Patient Care Team | 2 | 2015 | 267 | 0.390 |
Why?
| | Pilot Projects | 9 | 2022 | 725 | 0.390 |
Why?
| | Motivation | 2 | 2021 | 283 | 0.390 |
Why?
| | Physician-Patient Relations | 3 | 2016 | 142 | 0.390 |
Why?
| | Chronic Pain | 3 | 2023 | 189 | 0.380 |
Why?
| | Interleukin-6 | 5 | 2014 | 271 | 0.380 |
Why?
| | Disclosure | 1 | 2012 | 41 | 0.370 |
Why?
| | Symptom Assessment | 5 | 2018 | 32 | 0.370 |
Why?
| | Risk Assessment | 5 | 2013 | 1349 | 0.370 |
Why?
| | Prostatic Neoplasms | 5 | 2013 | 398 | 0.340 |
Why?
| | Mental Health | 3 | 2016 | 237 | 0.340 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2014 | 639 | 0.340 |
Why?
| | Patient Acceptance of Health Care | 2 | 2016 | 351 | 0.340 |
Why?
| | Risk Factors | 14 | 2022 | 3971 | 0.330 |
Why?
| | Medical Oncology | 4 | 2021 | 97 | 0.310 |
Why?
| | Attitude | 3 | 2018 | 73 | 0.310 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2016 | 504 | 0.310 |
Why?
| | Ethics Committees, Research | 2 | 2019 | 14 | 0.310 |
Why?
| | Attention | 4 | 2014 | 168 | 0.300 |
Why?
| | Clinical Protocols | 2 | 2006 | 106 | 0.300 |
Why?
| | Gastrointestinal Neoplasms | 2 | 2021 | 41 | 0.300 |
Why?
| | Parents | 1 | 2012 | 339 | 0.300 |
Why?
| | Feasibility Studies | 5 | 2020 | 404 | 0.290 |
Why?
| | California | 9 | 2020 | 92 | 0.280 |
Why?
| | Sleep | 4 | 2022 | 191 | 0.280 |
Why?
| | Smoking Cessation | 1 | 2011 | 316 | 0.280 |
Why?
| | Cognition | 2 | 2020 | 363 | 0.280 |
Why?
| | Age Factors | 12 | 2016 | 1120 | 0.270 |
Why?
| | Spirituality | 2 | 2018 | 30 | 0.270 |
Why?
| | Prevalence | 10 | 2017 | 1016 | 0.270 |
Why?
| | Neuropsychological Tests | 3 | 2012 | 346 | 0.260 |
Why?
| | Wakefulness | 3 | 2012 | 47 | 0.260 |
Why?
| | Aptitude | 1 | 2006 | 3 | 0.260 |
Why?
| | Clinical Competence | 1 | 2010 | 405 | 0.250 |
Why?
| | Emotions | 4 | 2021 | 172 | 0.250 |
Why?
| | Patient Selection | 5 | 2016 | 269 | 0.250 |
Why?
| | Life Change Events | 2 | 2017 | 35 | 0.240 |
Why?
| | Genotype | 8 | 2015 | 563 | 0.240 |
Why?
| | Young Adult | 11 | 2018 | 4346 | 0.240 |
Why?
| | Placebos | 1 | 2005 | 83 | 0.240 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2020 | 625 | 0.240 |
Why?
| | Phenotype | 8 | 2016 | 792 | 0.230 |
Why?
| | Random Allocation | 3 | 2017 | 286 | 0.210 |
Why?
| | Interviews as Topic | 3 | 2013 | 270 | 0.210 |
Why?
| | Follow-Up Studies | 4 | 2018 | 2294 | 0.200 |
Why?
| | Research Design | 6 | 2012 | 368 | 0.200 |
Why?
| | Psychometrics | 5 | 2007 | 238 | 0.200 |
Why?
| | Genetic Predisposition to Disease | 4 | 2014 | 525 | 0.200 |
Why?
| | Factor Analysis, Statistical | 7 | 2017 | 89 | 0.200 |
Why?
| | Pain, Postoperative | 2 | 2014 | 169 | 0.190 |
Why?
| | Promoter Regions, Genetic | 3 | 2013 | 465 | 0.190 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2014 | 390 | 0.180 |
Why?
| | Career Choice | 1 | 2003 | 117 | 0.180 |
Why?
| | Analysis of Variance | 5 | 2013 | 558 | 0.180 |
Why?
| | Antipsychotic Agents | 4 | 2006 | 234 | 0.180 |
Why?
| | Psychotherapy, Brief | 1 | 2021 | 9 | 0.180 |
Why?
| | Chi-Square Distribution | 5 | 2015 | 292 | 0.170 |
Why?
| | Vulnerable Populations | 2 | 2011 | 51 | 0.170 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2021 | 72 | 0.170 |
Why?
| | Mood Disorders | 1 | 2021 | 60 | 0.170 |
Why?
| | Prospective Studies | 9 | 2021 | 2433 | 0.170 |
Why?
| | Age Distribution | 4 | 2014 | 176 | 0.170 |
Why?
| | Physical Endurance | 1 | 2020 | 35 | 0.160 |
Why?
| | United States | 12 | 2020 | 5215 | 0.160 |
Why?
| | Hospice Care | 2 | 2012 | 17 | 0.160 |
Why?
| | Health Status | 4 | 2023 | 300 | 0.160 |
Why?
| | Epigenesis, Genetic | 1 | 2023 | 396 | 0.150 |
Why?
| | Physician's Role | 1 | 2019 | 50 | 0.150 |
Why?
| | Constipation | 1 | 2019 | 38 | 0.150 |
Why?
| | Employment | 1 | 2020 | 94 | 0.150 |
Why?
| | Taste | 1 | 2019 | 31 | 0.150 |
Why?
| | Cohort Studies | 3 | 2017 | 1576 | 0.150 |
Why?
| | Breast | 2 | 2021 | 86 | 0.150 |
Why?
| | Diarrhea | 1 | 2019 | 95 | 0.150 |
Why?
| | Genetics | 1 | 2018 | 5 | 0.150 |
Why?
| | Abdominal Pain | 1 | 2019 | 83 | 0.150 |
Why?
| | Socioeconomic Factors | 4 | 2017 | 609 | 0.150 |
Why?
| | Premenopause | 1 | 2018 | 28 | 0.140 |
Why?
| | Ruthenium Radioisotopes | 1 | 2018 | 1 | 0.140 |
Why?
| | Logistic Models | 4 | 2013 | 930 | 0.140 |
Why?
| | Tape Recording | 1 | 2018 | 7 | 0.140 |
Why?
| | New York City | 1 | 2018 | 25 | 0.140 |
Why?
| | Proton Therapy | 1 | 2018 | 12 | 0.140 |
Why?
| | Cholinergic Agents | 1 | 2017 | 5 | 0.140 |
Why?
| | Lung Neoplasms | 2 | 2017 | 643 | 0.140 |
Why?
| | Brachytherapy | 1 | 2018 | 50 | 0.140 |
Why?
| | Social Stigma | 1 | 2018 | 50 | 0.140 |
Why?
| | Postmenopause | 1 | 2018 | 104 | 0.140 |
Why?
| | Postoperative Period | 2 | 2014 | 169 | 0.130 |
Why?
| | Actigraphy | 6 | 2012 | 24 | 0.130 |
Why?
| | Antibodies | 1 | 2017 | 144 | 0.130 |
Why?
| | Menopause | 1 | 2017 | 55 | 0.130 |
Why?
| | STAT Transcription Factors | 1 | 2017 | 8 | 0.130 |
Why?
| | Janus Kinases | 1 | 2017 | 8 | 0.130 |
Why?
| | Specialization | 1 | 2017 | 48 | 0.130 |
Why?
| | Multivariate Analysis | 3 | 2013 | 601 | 0.130 |
Why?
| | Certification | 1 | 2017 | 52 | 0.130 |
Why?
| | Hand Strength | 1 | 2016 | 25 | 0.130 |
Why?
| | Sex Characteristics | 3 | 2015 | 210 | 0.130 |
Why?
| | Upper Extremity | 1 | 2016 | 45 | 0.120 |
Why?
| | Sex Distribution | 2 | 2014 | 138 | 0.120 |
Why?
| | Depression, Postpartum | 1 | 2016 | 45 | 0.120 |
Why?
| | Inflammasomes | 1 | 2017 | 64 | 0.120 |
Why?
| | Range of Motion, Articular | 1 | 2016 | 110 | 0.120 |
Why?
| | Brain | 2 | 2020 | 1337 | 0.120 |
Why?
| | Primary Health Care | 1 | 2019 | 387 | 0.120 |
Why?
| | Survival Analysis | 1 | 2017 | 656 | 0.120 |
Why?
| | Health Services Needs and Demand | 2 | 2014 | 161 | 0.120 |
Why?
| | Qualitative Research | 1 | 2018 | 365 | 0.120 |
Why?
| | Pain Measurement | 5 | 2015 | 263 | 0.120 |
Why?
| | Family | 2 | 2014 | 170 | 0.120 |
Why?
| | NF-kappa B | 1 | 2017 | 326 | 0.110 |
Why?
| | Cluster Analysis | 3 | 2023 | 236 | 0.110 |
Why?
| | Potassium Channels | 1 | 2015 | 31 | 0.110 |
Why?
| | Risk | 2 | 2016 | 315 | 0.110 |
Why?
| | Serotonin Agents | 1 | 2014 | 14 | 0.110 |
Why?
| | Catecholamines | 1 | 2014 | 44 | 0.110 |
Why?
| | Individuality | 3 | 2021 | 29 | 0.110 |
Why?
| | Treatment Refusal | 2 | 2006 | 35 | 0.110 |
Why?
| | Professional Role | 1 | 2015 | 79 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2007 | 1223 | 0.110 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2014 | 64 | 0.110 |
Why?
| | Receptors, Interferon | 1 | 2014 | 4 | 0.110 |
Why?
| | Models, Statistical | 2 | 2012 | 230 | 0.110 |
Why?
| | Lymph Node Excision | 3 | 2021 | 133 | 0.110 |
Why?
| | Sex Factors | 5 | 2020 | 735 | 0.110 |
Why?
| | Data Collection | 3 | 2011 | 285 | 0.110 |
Why?
| | Drug Therapy | 2 | 2006 | 46 | 0.110 |
Why?
| | Receptors, Interleukin-1 Type I | 1 | 2013 | 2 | 0.110 |
Why?
| | Educational Status | 3 | 2020 | 227 | 0.110 |
Why?
| | Australia | 4 | 2015 | 97 | 0.100 |
Why?
| | NF-kappa B p52 Subunit | 1 | 2013 | 6 | 0.100 |
Why?
| | Linear Models | 4 | 2020 | 288 | 0.100 |
Why?
| | Cooperative Behavior | 1 | 2015 | 224 | 0.100 |
Why?
| | Regression Analysis | 4 | 2015 | 400 | 0.100 |
Why?
| | Adolescent | 6 | 2016 | 6713 | 0.100 |
Why?
| | Incidence | 2 | 2013 | 1096 | 0.100 |
Why?
| | Obesity | 1 | 2020 | 1176 | 0.090 |
Why?
| | Affect | 2 | 2023 | 107 | 0.090 |
Why?
| | Chemotherapy, Adjuvant | 3 | 2017 | 122 | 0.090 |
Why?
| | Activity Cycles | 1 | 2012 | 4 | 0.090 |
Why?
| | Genetic Association Studies | 4 | 2014 | 124 | 0.090 |
Why?
| | Diagnostic Self Evaluation | 1 | 2011 | 13 | 0.090 |
Why?
| | Treatment Failure | 1 | 2011 | 117 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2012 | 113 | 0.090 |
Why?
| | Postoperative Complications | 2 | 2016 | 1065 | 0.090 |
Why?
| | Preoperative Period | 3 | 2018 | 47 | 0.090 |
Why?
| | Suicide | 2 | 2009 | 85 | 0.090 |
Why?
| | Family Relations | 1 | 2011 | 23 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1099 | 0.090 |
Why?
| | Ethics, Medical | 1 | 2011 | 44 | 0.080 |
Why?
| | Evidence-Based Practice | 1 | 2011 | 108 | 0.080 |
Why?
| | Inpatients | 1 | 2011 | 203 | 0.080 |
Why?
| | Patient Satisfaction | 1 | 2011 | 287 | 0.080 |
Why?
| | Case-Control Studies | 4 | 2017 | 1202 | 0.080 |
Why?
| | Knowledge | 2 | 2007 | 28 | 0.080 |
Why?
| | Government Regulation | 1 | 2009 | 14 | 0.080 |
Why?
| | Social Support | 1 | 2011 | 270 | 0.080 |
Why?
| | New Mexico | 1 | 2009 | 12 | 0.080 |
Why?
| | Predictive Value of Tests | 3 | 2012 | 938 | 0.080 |
Why?
| | Prejudice | 1 | 2009 | 37 | 0.070 |
Why?
| | Guidelines as Topic | 1 | 2009 | 111 | 0.070 |
Why?
| | Terminally Ill | 1 | 2008 | 12 | 0.070 |
Why?
| | Mental Health Services | 1 | 2011 | 207 | 0.070 |
Why?
| | Attitude to Health | 1 | 2010 | 191 | 0.070 |
Why?
| | Karnofsky Performance Status | 3 | 2012 | 10 | 0.070 |
Why?
| | Time Factors | 4 | 2017 | 2987 | 0.070 |
Why?
| | Demography | 2 | 2022 | 92 | 0.070 |
Why?
| | Axilla | 2 | 2020 | 92 | 0.070 |
Why?
| | Smoking | 1 | 2011 | 514 | 0.070 |
Why?
| | Inflammation | 1 | 2012 | 649 | 0.070 |
Why?
| | Mass Screening | 2 | 2007 | 354 | 0.070 |
Why?
| | Brain Neoplasms | 1 | 2011 | 302 | 0.070 |
Why?
| | Reference Standards | 1 | 2006 | 51 | 0.060 |
Why?
| | Canada | 2 | 2019 | 112 | 0.060 |
Why?
| | Problem Solving | 1 | 2006 | 42 | 0.060 |
Why?
| | Decision Support Techniques | 1 | 2007 | 73 | 0.060 |
Why?
| | Statistics as Topic | 1 | 2006 | 89 | 0.060 |
Why?
| | Prognosis | 3 | 2018 | 2100 | 0.060 |
Why?
| | Bipolar Disorder | 1 | 2007 | 197 | 0.060 |
Why?
| | Infant, Newborn | 1 | 2012 | 2871 | 0.060 |
Why?
| | Sensitivity and Specificity | 3 | 2016 | 871 | 0.050 |
Why?
| | Haplotypes | 2 | 2014 | 95 | 0.050 |
Why?
| | Patient Care Planning | 1 | 2004 | 68 | 0.050 |
Why?
| | Bioethical Issues | 1 | 2003 | 11 | 0.050 |
Why?
| | Causality | 2 | 2014 | 51 | 0.050 |
Why?
| | Personal Satisfaction | 1 | 2023 | 74 | 0.050 |
Why?
| | Disease Progression | 2 | 2017 | 870 | 0.050 |
Why?
| | Reference Values | 1 | 2002 | 316 | 0.040 |
Why?
| | Grief | 1 | 2021 | 7 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2018 | 5508 | 0.040 |
Why?
| | Alleles | 2 | 2013 | 279 | 0.040 |
Why?
| | Polymorphism, Genetic | 2 | 2014 | 184 | 0.040 |
Why?
| | Nucleus Accumbens | 1 | 2020 | 26 | 0.040 |
Why?
| | Motor Activity | 2 | 2012 | 227 | 0.040 |
Why?
| | Patient Compliance | 1 | 2002 | 228 | 0.040 |
Why?
| | Interdisciplinary Communication | 2 | 2015 | 57 | 0.040 |
Why?
| | Religion | 1 | 2020 | 61 | 0.040 |
Why?
| | ROC Curve | 2 | 2012 | 249 | 0.040 |
Why?
| | Mastectomy, Segmental | 1 | 2020 | 94 | 0.040 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2020 | 119 | 0.040 |
Why?
| | Physicians, Family | 1 | 2019 | 64 | 0.040 |
Why?
| | DNA Methylation | 1 | 2023 | 573 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2005 | 570 | 0.040 |
Why?
| | Morals | 1 | 2018 | 48 | 0.040 |
Why?
| | Population Groups | 1 | 2018 | 8 | 0.040 |
Why?
| | Curriculum | 2 | 2011 | 406 | 0.030 |
Why?
| | Drugs, Investigational | 1 | 2017 | 14 | 0.030 |
Why?
| | Hypesthesia | 1 | 2017 | 16 | 0.030 |
Why?
| | Amyloid | 1 | 2017 | 36 | 0.030 |
Why?
| | Nausea | 1 | 2017 | 44 | 0.030 |
Why?
| | Back Pain | 1 | 2017 | 39 | 0.030 |
Why?
| | Consent Forms | 1 | 2016 | 7 | 0.030 |
Why?
| | Mammaplasty | 1 | 2016 | 43 | 0.030 |
Why?
| | Periodicity | 1 | 2016 | 25 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2016 | 235 | 0.030 |
Why?
| | Veterans | 1 | 2002 | 573 | 0.030 |
Why?
| | Immunotherapy | 1 | 2017 | 251 | 0.030 |
Why?
| | Geriatric Assessment | 1 | 2016 | 109 | 0.030 |
Why?
| | Fellowships and Scholarships | 1 | 2017 | 123 | 0.030 |
Why?
| | Executive Function | 1 | 2016 | 85 | 0.030 |
Why?
| | Neoadjuvant Therapy | 1 | 2016 | 124 | 0.030 |
Why?
| | Forecasting | 1 | 2015 | 151 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2001 | 1507 | 0.030 |
Why?
| | Disability Evaluation | 1 | 2014 | 92 | 0.030 |
Why?
| | Time | 1 | 2014 | 29 | 0.030 |
Why?
| | Perception | 1 | 2015 | 121 | 0.030 |
Why?
| | Genetic Testing | 1 | 2015 | 130 | 0.030 |
Why?
| | Data Interpretation, Statistical | 1 | 2015 | 166 | 0.030 |
Why?
| | Genetic Markers | 1 | 2014 | 108 | 0.030 |
Why?
| | Focus Groups | 1 | 2015 | 201 | 0.030 |
Why?
| | Homozygote | 1 | 2013 | 58 | 0.030 |
Why?
| | Heterozygote | 1 | 2013 | 89 | 0.030 |
Why?
| | Cancer Care Facilities | 1 | 2013 | 20 | 0.030 |
Why?
| | Urination | 1 | 2013 | 20 | 0.030 |
Why?
| | Watchful Waiting | 1 | 2013 | 29 | 0.030 |
Why?
| | Sexuality | 1 | 2013 | 14 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2013 | 122 | 0.020 |
Why?
| | Exercise | 1 | 2017 | 559 | 0.020 |
Why?
| | Prostatectomy | 1 | 2013 | 84 | 0.020 |
Why?
| | San Francisco | 1 | 2012 | 12 | 0.020 |
Why?
| | Disorders of Excessive Somnolence | 1 | 2012 | 7 | 0.020 |
Why?
| | Sleep Stages | 1 | 2012 | 41 | 0.020 |
Why?
| | Interleukin-18 Receptor alpha Subunit | 1 | 2012 | 1 | 0.020 |
Why?
| | Interleukin-3 | 1 | 2012 | 12 | 0.020 |
Why?
| | Preoperative Care | 1 | 2013 | 173 | 0.020 |
Why?
| | Women's Health | 1 | 2012 | 87 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2016 | 853 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2012 | 181 | 0.020 |
Why?
| | Interview, Psychological | 1 | 2011 | 23 | 0.020 |
Why?
| | Odds Ratio | 1 | 2013 | 563 | 0.020 |
Why?
| | Hospitalization | 2 | 2008 | 731 | 0.020 |
Why?
| | Rest | 1 | 2011 | 60 | 0.020 |
Why?
| | Goals | 1 | 2011 | 45 | 0.020 |
Why?
| | Schools, Medical | 1 | 2011 | 68 | 0.020 |
Why?
| | Polysomnography | 1 | 2010 | 76 | 0.020 |
Why?
| | Models, Biological | 1 | 2013 | 735 | 0.020 |
Why?
| | Cost of Illness | 1 | 2011 | 120 | 0.020 |
Why?
| | Gene Frequency | 1 | 2010 | 97 | 0.020 |
Why?
| | Nursing Methodology Research | 1 | 2010 | 33 | 0.020 |
Why?
| | Clinical Nursing Research | 1 | 2009 | 10 | 0.020 |
Why?
| | Pregnancy | 1 | 2016 | 2642 | 0.020 |
Why?
| | Electroencephalography | 1 | 2010 | 301 | 0.020 |
Why?
| | Personality Disorders | 1 | 2008 | 22 | 0.020 |
Why?
| | Federal Government | 1 | 2008 | 4 | 0.020 |
Why?
| | Virginia | 1 | 2008 | 18 | 0.020 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2008 | 44 | 0.020 |
Why?
| | Bioethics | 1 | 2007 | 15 | 0.020 |
Why?
| | Matched-Pair Analysis | 1 | 2007 | 11 | 0.020 |
Why?
| | Audiovisual Aids | 1 | 2007 | 13 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2008 | 186 | 0.020 |
Why?
| | Reading | 1 | 2007 | 76 | 0.020 |
Why?
| | Empiricism | 1 | 2005 | 1 | 0.020 |
Why?
| | Chronic Disease | 1 | 2008 | 579 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2008 | 317 | 0.010 |
Why?
| | Length of Stay | 1 | 2008 | 673 | 0.010 |
Why?
| | Intelligence Tests | 1 | 2004 | 39 | 0.010 |
Why?
| | Advisory Committees | 1 | 2003 | 74 | 0.010 |
Why?
| | Probability | 1 | 2002 | 171 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2008 | 6694 | 0.010 |
Why?
|
|
Dunn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|